Biofilms

Debridement: The Next Clinical Advantage in TIME

12/10/2018

Elliot T. Walters, MD

Patricia Stevenson, MSN, ACNS-BC, CWS

Editor’s Note: This is the first in a series of articles on biofilm that will publish in Today’s Wound Clinic.

Editor’s Note: This is the first...

12/10/2018

Today's Wound Clinic

Infected Wounds

Emerging Innovations in the Prevention & Treatment of Chronic Wound Infections

05/08/2018

Sarah Waterman Manning, MD; Michael Schurr, MD; & David Humphrey, MD, CWSP, FACCWS

Sarah Waterman Manning, MD; Michael S...

The burden of chronic wounds in United States continues to mount for our healthcare system. Recent cost estimates in this country are near $25 billion per year with 6.5 million patients treated annually.1 Chronic wounds, defined as those that...

The burden of chronic wounds in...

05/08/2018

Today's Wound Clinic

Pharmacologic Management of Bacterial Biofilms

09/15/2016

Daniel B. Chastain, PharmD, AAHIVP

Daniel B. Chastain, PharmD, AAHIVP ...

The organisms residing in biofilms are dormant and represent a therapeutic problem. Management of biofilm relies on surgical debridement and utilization of antimicrobial agents that can eliminate biofilm-associated microorganisms.

The organisms residing in...

09/15/2016

Today's Wound Clinic

Providing A Biofilm Explanation For Ablative Treatment of Recalcitrant Wounds

09/15/2016

Randall Wolcott, MD, CWS

This article provides current treatment advice as well as recent patient case studies.

This article provides current...

09/15/2016

Today's Wound Clinic

The Evolving Approach to Biofilm in Wound Care Settings

02/13/2015

Jennifer Hurlow, GNP-BC, CWOCN

Clinicians should focus more targeted efforts toward combating chronic, biofilm-related infections and paying more attention to their impact on patients and our collective health system.

Clinicians should focus more...

02/13/2015

Today's Wound Clinic